Meizi Jiang

803 total citations
35 papers, 609 citations indexed

About

Meizi Jiang is a scholar working on Immunology, Immunology and Allergy and Surgery. According to data from OpenAlex, Meizi Jiang has authored 35 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 12 papers in Immunology and Allergy and 10 papers in Surgery. Recurrent topics in Meizi Jiang's work include Cell Adhesion Molecules Research (12 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (6 papers). Meizi Jiang is often cited by papers focused on Cell Adhesion Molecules Research (12 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Adipokines, Inflammation, and Metabolic Diseases (6 papers). Meizi Jiang collaborates with scholars based in Japan, Austria and Netherlands. Meizi Jiang's co-authors include Hideaki Bujo, Yasushi Saitō, Wolfgang J. Schneider, Hiroyuki Yamazaki, Kenji Ohwaki, Manabu Shibasaki, Hiroyuki Ebinuma, Tatsuro Kanaki, Kazuo Takahashi and M Takahashi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Meizi Jiang

35 papers receiving 608 citations

Peers

Countries citing papers authored by Meizi Jiang

Since Specialization

Citations

This map shows the geographic impact of Meizi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meizi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meizi Jiang more than expected).

Fields of papers citing papers by Meizi Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meizi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meizi Jiang. The network helps show where Meizi Jiang may publish in the future.

Co-authorship network of co-authors of Meizi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Meizi Jiang. A scholar is included among the top collaborators of Meizi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meizi Jiang. Meizi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia 2019 ·Clinica Chimica Acta ·Hiroaki Ishida, Meizi Jiang, Hiroyuki Ebinuma, Nobuyuki Hiruta, Wolfgang J. Schneider, Toshihiko Kinoshita, Hideaki Bujo	3
2	Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia 2017 ·Atherosclerosis ·Ranitha Vongpromek, Sven Bos, (unknown), Hideaki Bujo, Meizi Jiang, Koen Nieman, Wolfgang J. Schneider, Jeanine E. Roeters van Lennep, Adrie J.M. Verhoeven, Eric J.G. Sijbrands, Monique T. Mulder	5
3	Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers 2016 ·Clinica Chimica Acta ·(unknown), Meizi Jiang, Wataru Tokuyama, Takeyoshi Murano, Nobuo Takada, (unknown), Hiroyuki Ebinuma, Toshihiko Kishimoto, Nobuyuki Hiruta, Wolfgang J. Schneider, Hideaki Bujo	16
4	Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes 2016 ·Clinica Chimica Acta ·(unknown), Meizi Jiang, (unknown), (unknown), Takeyoshi Murano, Nobuyuki Hiruta, Hiroyuki Ebinuma, (unknown), Wolfgang J. Schneider, Hideaki Bujo	7
5	Levels of the soluble LDL receptor-relative LR11 decrease in overweight individuals with type 2 diabetes upon diet-induced weight loss 2016 ·Atherosclerosis ·Kirsten A. Berk, Ranitha Vongpromek, Meizi Jiang, Wolfgang J. Schneider, Reinier Timman, Adrie J.M. Verhoeven, Hideaki Bujo, Eric J.G. Sijbrands, Monique T. Mulder	10
6	Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease 2015 ·Atherosclerosis ·Kenichi Watanabe, Hiroshi Suzuki, Meizi Jiang, (unknown), (unknown), Satoshi Hoshina, Akihiko Saitoh, Makoto Uchiyama, Hideaki Bujo	1
7	Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease 2015 ·Atherosclerosis ·Manabu Ogita, Katsumi Miyauchi, Takatoshi Kasai, Shuta Tsuboi, Hideki Wada, Ryo Naito, Hirokazu Konishi, Tomotaka Dohi, Hiroshi Tamura, Shinya Okazaki, Naotake Yanagisawa, Kazunori Shimada, Satoru Suwa, Meizi Jiang, Hideaki Bujo, Hiroyuki Daida	2
8	Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans 2015 ·Nature Communications ·Andrew J. Whittle, Meizi Jiang, Vivian Peirce, Joana Relat, Sam Virtue, Hiroyuki Ebinuma, Isamu Fukamachi, Takashi Yamaguchi, M Takahashi, Takeyoshi Murano, Ichiro Tatsuno, Masahiro Takeuchi, Chiaki Nakaseko, (unknown), Zhehu Jin, Mark Campbell, Wolfgang J. Schneider, Antonio Vidal‐Puig, Hideaki Bujo	55
9	LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients 2015 ·Atherosclerosis ·Ranitha Vongpromek, Hideaki Bujo, Menno Hoekstra, Wolfgang J. Schneider, (unknown), Arend F. L. Schinkel, Suzanne J.A. Korporaal, Willem A. Dik, Hiroyuki Ebinuma, Meizi Jiang, Adrie J.M. Verhoeven, Eric J.G. Sijbrands, Monique T. Mulder	6
10	G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow 2014 ·Annals of Hematology ·Naomi Shimizu, Chiaki Nakaseko, Meizi Jiang, (unknown), Koutaro Yokote, Tohru Iseki, Morihiro Higashi, Jun‐ichi Tamaru, Wolfgang J. Schneider, Hideaki Bujo	5
11	Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma 2014 ·Clinica Chimica Acta ·(unknown), Hiroyuki Ebinuma, Isamu Fukamachi, Chikako Ohwada, (unknown), Naomi Shimizu, Masahiro Takeuchi, Emiko Sakaida, Meizi Jiang, Chiaki Nakaseko, Hideaki Bujo	9
12	The Soluble Form of LR11 Protein Is a Regulator of Hypoxia-induced, Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Adhesion of Immature Hematological Cells 2013 ·Journal of Biological Chemistry ·(unknown), Chiaki Nakaseko, Meizi Jiang, Naomi Shimizu, Masahiro Takeuchi, Wolfgang J. Schneider, Hideaki Bujo	19
13	Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy 2013 ·Graefe s Archive for Clinical and Experimental Ophthalmology ·Tomoaki Shiba, Hideaki Bujo, M Takahashi, (unknown), Meizi Jiang, Yuichi Hori, Takatoshi Maeno, Kohji Shirai	7
14	Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias 2012 ·Clinica Chimica Acta ·(unknown), Chiaki Nakaseko, Masahiro Takeuchi, Chikako Ohwada, Naomi Shimizu, Shokichi Tsukamoto, (unknown), Meizi Jiang, Yasunori Sato, Hiroyuki Ebinuma, Koutaro Yokote, Atsushi Iwama, Isamu Fukamachi, Wolfgang J. Schneider, Yasushi Saitō, Hideaki Bujo	15
15	Enhanced Circulating Soluble LR11 in Patients With Diabetic Retinopathy 2012 ·American Journal of Ophthalmology ·M Takahashi, Hideaki Bujo, Tomoaki Shiba, Meizi Jiang, Takatoshi Maeno, Kohji Shirai	14
16	Increased circulating soluble LR11 in patients with acute coronary syndrome 2012 ·Clinica Chimica Acta ·Manabu Ogita, Katsumi Miyauchi, Tomotaka Dohi, Shuta Tsuboi, Tadashi Miyazaki, Takayuki Yokoyama, Ken Yokoyama, Kazunori Shimada, Takeshi Kurata, Meizi Jiang, Hideaki Bujo, Hiroyuki Daida	17
17	Enhanced circulating soluble LR11 in patients with coronary organic stenosis 2009 ·Atherosclerosis ·M Takahashi, Hideaki Bujo, Meizi Jiang, Hirofumi Noike, Yasushi Saitō, Kohji Shirai	27
18	Ang II–stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice 2008 ·Journal of Clinical Investigation ·Meizi Jiang, Hideaki Bujo, Kenji Ohwaki, Hiroyuki Unoki‐Kubota, Hiroyuki Yamazaki, Tatsuro Kanaki, Manabu Shibasaki, (unknown), Kenichi Harigaya, Wolfgang J. Schneider, Yasushi Saitō	47
19	Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells 2006 ·Biochemical and Biophysical Research Communications ·Meizi Jiang, Hideaki Bujo, (unknown), Hiroyuki Yamazaki, Satoshi Hirayama, Tatsuro Kanaki, Manabu Shibasaki, Kazuo Takahashi, Wolfgang J. Schneider, Yasushi Saitō	28
20	LRP1B is a negative modulator of increased migration activity of intimal smooth muscle cells from rabbit aortic plaques 2005 ·Biochemical and Biophysical Research Communications ·(unknown), Hideaki Bujo, Meizi Jiang, (unknown), Kazuo Takahashi, Kazuo Yagui, Naotake Hashimoto, Wolfgang J. Schneider, Yasushi Saitō	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact